Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune- type disorders in mice

Journal of Experimental Medicine

Volumn 185, Issue 2, 1997, Pages 329-339

  Erb, Klaus J ^a   Rüger, Beate ^a   Von Brevern, Maja ^b   Ryffel, Bernhard ^c   Schimpl, Annelise ^b   Rivett, Karen ^a  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; GENE DELETION; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; FEMALE; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; SUPERANTIGENS;

EID: 1842417145     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.2.329     Document Type: Article

References (36)

1. Singer, G.G., A.C. Carrera, R.A. Marshak, C. Martinez, and A.K. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6:913-920.
2. Theofilopoulos, A.N. 1995. The basis of autoimmunity: Part II. Genetic predisposition. Immunol. Today. 16:150-159.
3. Theofilopoulos, A.N. 1995. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol. Today. 16:90-98.
4. Arnold, B., G. Schonrich, and G.J. Hammerling. 1993. Multiple levels of peripheral tolerance. Immunol. Today 14:12-14.
5. Avrameas, S. 1991. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol. Today 12:154-159.
6. Hämmerling, G.J., G. Schonrich, I. Ferber, and B. Arnold. 1993. Peripheral tolerance as a multi-step mechanism. Immunol. Rev. 133:93-104.
7. Pircher, H., K. Buerki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature (Lond.). 342:559-561.
8. Strasser, A., A.W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
9. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory, and A.W. Harris. 1991. Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88: 8661-8665.
10. Brines, R.D., and G.G. Klaus. 1993. Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand. Int. Immunol. 5:1445-1450.
11. Illera, V.A., C.E. Perandones, L.L. Stunz, D.J. Mower, and R.F. Ashman. 1993. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J. Immunol. 151: 2965-2973.
12. Norvell, A., E. Mandik, and J.G. Monroe. 1995. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. J. Immunol. 154:4404-4413.
13. Parry, S.E., M.J. Holman, J. Hasbold, and G.G. Klaus. 1994. Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur. J. Immunol. 24:974-979.
14. Parry, S.E., J. Hasbold, M. Holman, and G.G. Klaus. 1994. Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J. Immunol. 152:2821-2829.
15. Ohashi, P.S., H. Pircher, K. Buerki, R.M. Zinkernagel, and H. Hengartner. 1990. Distinct sequence of negative or positive selection implied by thymocyte T-cell receptor densities. Nature (Lond.). 346:861-863.
16. Erb, K.J., T. Holtschke, K. Muth, I. Horak, and A. Schimpl. 1994. T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences. Eur. J. Immunol. 24:1143-1147.
17. Erb, K.J., T. Hanke, A. Schimpl, T. Hunig, G. Stingl, and A. Elbe. 1995. Impaired survival of T cell receptor V gamma 3+ cells in interleukin-4 transgenic mice. Eur. J. Immunol. 25: 1442-1445.
18. Lane, P., W. Gerhard, S. Hubele, A. Lanzavecchia, and F. McConnell. 1993. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1. Immunology. 80:56-61.
19. Ronchese, F., B. Hausmann, S. Hubele, and P. Lane. 1994. Mice transgenic for a soluble form of murine CTLA-4 show enhanced expansion of antigen-specific CD4+ T cells and defective antibody production in vivo. J. Exp. Med. 179:809-817.
20. Wohlleben, G., D. Gray, and A. Schimpl. 1996. In vitro immunisation of naive mouse B cells: establishment of IgM secreting hybridomas specific for soluble protein or hapten from B cells cultured on CD40 ligand transfected mouse fibroblasts. Int. Immunol. 8:343-349.
21. Hardy, R.R., and K. Hayakawa. 1986. Development and physiology of Ly-1 B and its human homolog, Leu-1 B. Immmunol. Rev. 93:53-79.
22. Klinman, D.M., and A.D. Steinberg. 1987. Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165:1755-1760.
23. Steinberg, A.D., A.M. Krieg, M.F. Gourley, and D.M. Klinman. 1990. Theoretical and experimental approaches to generalized autoimmunity. Immunol. Rev. 118:129-163.
24. Acha, O.H., and H.R. MacDonald. 1995. Superantigens of mouse mammary tumor virus. Annu. Rev. Immunol. 13: 459-486.
25. Hodes, R.J., and R. Abe. 1992. T cell recognition of Mislike superantigens: analysis of TCR requirements, superantigenic ligands, and signal transduction. Semin. Immunol. 4: 319-327.
26. Eschbach, J.W., and J.W. Adamson. 1991. The pathophysiology and treatment of the anemia of chronic renal failure. In Current Nephrology. H.C. Gonick, editor. Moshy Year Book Press, NY. 259-291.
27. Eastcott, J.W., R.S. Schwartz, and S.K. Datta. 1983. Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB X SWR crosses. J. Immunol. 131:2232-2239.
28. Boumpas, D.T., H. Austin III, B.J. Fessler, J.E. Balow, J.H. Klippel, and M.D. Lockshin. 1995. Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Int. Med. 122:940-950.
29. Nemazee, D., and Buerki, K. 1989. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl. Acad. Sci. USA. 86:8039-8043.
30. Nemazee, D.A., and K. Buerki. 1989. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature (Lond.). 337:562-566.
31. Muller, W., R. Kuhn, and K. Rajewsky. 1991. Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulmemia. Eur. J. Immunol. 21: 921-925.
32. Tepper, R.I., D.A. Levinson, B.Z. Stanger, T.J. Campos, A.K. Abbas, and P. Leder. 1990. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell. 62:457-467.
33. Lewis, D.B., C.C. Yu, K.A. Forbush, J. Carpenter, T.A. Sato, A. Grossman, D.H. Liggitt, and R.M. Perlmutter. 1991. Interleukin 4 expressed in situ selectively alters thymocyte development. J. Exp. Med. 173:89-100.
34. Ushiyama, C., T. Hirano, H. Miyajima, K. Okumura, Z. Ovary, and H. Hashimoto. 1995. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation - the IgE allotype is an important marker of graft-versus-host disease. J. Immunol. 154:2687-2696.
35. Bonomo, A., P.J. Kehn, E. Payer, L. Rizzo, A.W. Cheever, and E.M. Shevach. 1995. Pathogenesis of post-thymectomy autoimmunity-role of syngeneic mlr-reactive T cells. J. Immunol. 154:6602-6611.
36. Rocken, M., M. Racke, and E.M. Shevach. 1996. IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17:225-231.